Hematologi

Respiratory syncytial virus and other vaccine-preventable infections in multiple myeloma: A population-based study on 8,672 myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry

Einarsdottir, Sigrun; Sverrisdottir, Ingigerdur; Villegas-Scivetti, Mariana; Day, Chris et al.

Ingår i Haematologica, s. 179-182, 2025

• DOI för Respiratory syncytial virus and other vaccine-preventable infections in multiple myeloma: A population-based study on 8,672 myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry
• Ladda ner fulltext (pdf) av Respiratory syncytial virus and other vaccine-preventable infections in multiple myeloma: A population-based study on 8,672 myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry

Epidemiology of mastocytosis: a population-based study (Sweden)

Bergström, Anna; Hägglund, Hans; Berglund, Anders; Nilsson, Gunnar et al.

Ingår i Acta Oncologica, s. 44-50, 2024

• DOI för Epidemiology of mastocytosis: a population-based study (Sweden)
• Ladda ner fulltext (pdf) av Epidemiology of mastocytosis: a population-based study (Sweden)

Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry

Brioli, Annamaria; Lomaia, Elza; Fabisch, Christian; Sacha, Tomasz et al.

Ingår i Leukemia, s. 1072-1080, 2024

• DOI för Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry
• Ladda ner fulltext (pdf) av Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry

Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS-M) prediction in myelodysplastic syndromes

Creignou, Maria; Bernard, Elsa; Gasparini, Alessandro; Tranberg, Anna et al.

Ingår i Journal of Internal Medicine, s. 53-67, 2024

• DOI för Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS-M) prediction in myelodysplastic syndromes
• Ladda ner fulltext (pdf) av Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS-M) prediction in myelodysplastic syndromes

Systemic mastocytosis: dying or survivin

Dahlin, Joakim S.; Nilsson, Gunnar

Ingår i Blood, s. 945-947, 2024

• DOI för Systemic mastocytosis: dying or survivin

Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial

Efficace, Fabio; Mahon, Francois-Xavier; Richter, Johan; Piciocchi, Alfonso et al.

Ingår i Leukemia, s. 1722-1730, 2024

• DOI för Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial

Clinical and Genetic studies in Chronic Myeloid Leukaemia

Flygt, Hjalmar

2024

• Ladda ner fulltext (pdf) av Clinical and Genetic studies in Chronic Myeloid Leukaemia

An optimized method for IgE-mediated degranulation of human lung mast cells

Gong, Yitao; Johnsson, Anna-Karin; Säfholm, Jesper; Al-Ameri, Mamdoh et al.

Ingår i Frontiers in Immunology, 2024

• DOI för An optimized method for IgE-mediated degranulation of human lung mast cells
• Ladda ner fulltext (pdf) av An optimized method for IgE-mediated degranulation of human lung mast cells

Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors

Gronvold, B. Linder; Ali, Maryan Mohamed; Myklebust, Tor Å; Lenartova, Andrea et al.

Ingår i eJHaem, s. 117-124, 2024

• DOI för Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors
• Ladda ner fulltext (pdf) av Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors

Patient perceived quality of cirrhosis care – adjunctive nurse-based care versus standard medical care: a pragmatic multicentre randomised controlled study

Hjorth, Maria; Svanberg, Anncarin; LoMartire, Riccardo; Kaminsky, Elenor et al.

Ingår i BMC Nursing, 2024

• DOI för Patient perceived quality of cirrhosis care – adjunctive nurse-based care versus standard medical care: a pragmatic multicentre randomised controlled study
• Ladda ner fulltext (pdf) av Patient perceived quality of cirrhosis care – adjunctive nurse-based care versus standard medical care: a pragmatic multicentre randomised controlled study

Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation

Huuhtanen, Jani; Adnan-Awad, Shady; Theodoropoulos, Jason; Forsten, Sofia et al.

Ingår i Leukemia, s. 109-125, 2024

• DOI för Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation
• Ladda ner fulltext (pdf) av Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation

Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis

Iribarren, Cristina; Levedahl, Kerstin; Atanasoai, Ionut; Mattsson, Mattias et al.

Ingår i Journal of Molecular Diagnostics, s. 792-804, 2024

• DOI för Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis
• Ladda ner fulltext (pdf) av Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis

Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM

Lübke, Johannes; Schmid, Alicia; Christen, Deborah; Elberink, Hanneke N. G. Oude et al.

Ingår i Blood Advances, s. 2890-2900, 2024

• DOI för Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM
• Ladda ner fulltext (pdf) av Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM

The exon-junction complex helicase eIF4A3 holds therapeutic potential in acute myeloid leukemia

Miliara, Sophia; Cozzi, Elisabetta; Zhong, Xiangfu; Chan, Isaac et al.

Ingår i Leukemia, s. 663-666, 2024

• DOI för The exon-junction complex helicase eIF4A3 holds therapeutic potential in acute myeloid leukemia
• Ladda ner fulltext (pdf) av The exon-junction complex helicase eIF4A3 holds therapeutic potential in acute myeloid leukemia

CRISPR/Cas9-mediated gene disruption determines the roles of MITF and CITED2 in human mast cell differentiation

Mo, Jiezhen; Wermeling, Fredrik; Nilsson, Gunnar; Dahlin, Joakim S.

Ingår i Blood Advances, s. 3941-3945, 2024

• DOI för CRISPR/Cas9-mediated gene disruption determines the roles of MITF and CITED2 in human mast cell differentiation
• Ladda ner fulltext (pdf) av CRISPR/Cas9-mediated gene disruption determines the roles of MITF and CITED2 in human mast cell differentiation

Antibiotic-induced microbiome disturbances in hematological patients undergoing hematopoietic stem cell transplantation: a prospective observational study

Montelin, Hanna; Hugerth, Luisa; Debelius, Justine; Melhus, Åsa et al.

2024

Incidence of cardiovascular disease in healthy Swedish peripheral blood stem cell donors - a nationwide study

Pahnke, Simon; Hägglund, Hans; Larfors, Gunnar

Ingår i Bone Marrow Transplantation, s. 403-408, 2024

• DOI för Incidence of cardiovascular disease in healthy Swedish peripheral blood stem cell donors - a nationwide study
• Ladda ner fulltext (pdf) av Incidence of cardiovascular disease in healthy Swedish peripheral blood stem cell donors - a nationwide study

Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data

Pang, Ian; Chen, Peggy; Trinh, Gertrude V.; Remberger, Mats et al.

Ingår i European Journal of Haematology, s. 301-309, 2024

• DOI för Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data

Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort Study

Pasic, Ivan; Moya, Tommy Alfaro; Remberger, Mats; Chen, Carol et al.

Ingår i Transplantation and Cellular Therapy, s. 6810-68100000000000, 2024

• DOI för Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort Study

Proteome-wide CETSA reveals diverse apoptosisinducing mechanisms converging on an initial apoptosis effector stage at the nuclear periphery

Ramos, Anderson Daniel; Liang, Ying Yu; Surova, Olga; Bacanu, Smaranda et al.

Ingår i Cell Reports, 2024

• DOI för Proteome-wide CETSA reveals diverse apoptosisinducing mechanisms converging on an initial apoptosis effector stage at the nuclear periphery
• Ladda ner fulltext (pdf) av Proteome-wide CETSA reveals diverse apoptosisinducing mechanisms converging on an initial apoptosis effector stage at the nuclear periphery

Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition

Roeth, Alexander; He, Guangsheng; Tong, Hongyan; Lin, Zenghua et al.

Ingår i American Journal of Hematology, s. 1768-1777, 2024

• DOI för Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition
• Ladda ner fulltext (pdf) av Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition

AL amyloidosis: Study of epidemiology, diagnosis and treatment with emphasis on heart involvement

Rosengren, Sara

2024

• Ladda ner fulltext (pdf) av AL amyloidosis: Study of epidemiology, diagnosis and treatment with emphasis on heart involvement

Outcome prediction by myocardial external efficiency from ¹¹C-acetate positron emission tomography in cardiac amyloidosis

Rosengren, Sara; Skibsted Clemmensen, Tor; Hvitfeldt Poulsen, Steen; Tolbod, Lars et al.

Ingår i ESC Heart Failure, s. 44-53, 2024

• DOI för Outcome prediction by myocardial external efficiency from ¹¹C-acetate positron emission tomography in cardiac amyloidosis
• Ladda ner fulltext (pdf) av Outcome prediction by myocardial external efficiency from ¹¹C-acetate positron emission tomography in cardiac amyloidosis

Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

Silfverberg, Thomas; Zjukovskaja, Christina; Ljungman, Per; Nahimi, Adjmal et al.

Ingår i Journal of Neurology, Neurosurgery and Psychiatry, s. 125-133, 2024

• DOI för Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study
• Ladda ner fulltext (pdf) av Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis

Silfverberg, Thomas; Zjukovskaja, Christina; Noui, Yassine; Carlson, Kristina et al.

Ingår i Bone Marrow Transplantation, s. 1601-1610, 2024

• DOI för BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis
• Ladda ner fulltext (pdf) av BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis

Delineating functional and molecular impact of ex vivo sample handling in precision medicine

Struyf, Nona; Österroos, Albin; Vesterlund, Mattias; Arnroth, Cornelia et al.

Ingår i npj Precision Oncology, 2024

• DOI för Delineating functional and molecular impact of ex vivo sample handling in precision medicine
• Ladda ner fulltext (pdf) av Delineating functional and molecular impact of ex vivo sample handling in precision medicine

Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation

Tobiasson, Magnus; Pandzic, Tatjana; Illman, Johanna; Nilsson, Lars et al.

Ingår i Journal of Clinical Oncology, 2024

• DOI för Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation

Toll-like receptor activation induces airway obstruction and hyperresponsiveness in guinea pigs

Xiang, Yujiao; Liu, Jielu; Nie, Mu; Nilsson, Gunnar et al.

Ingår i Respiratory Research, 2024

• DOI för Toll-like receptor activation induces airway obstruction and hyperresponsiveness in guinea pigs
• Ladda ner fulltext (pdf) av Toll-like receptor activation induces airway obstruction and hyperresponsiveness in guinea pigs

Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplantation

Carreira, Abel Santos; Salas, Maria Queralt; Remberger, Mats; Novitzky-Basso, Igor et al.

Ingår i Transplantation and Cellular Therapy, s. 5810-58100000000, 2023

• DOI för Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplantation

The impact of Covid-19 in patients with chronic myeloid leukemia: a nationwide population-based study

Dahlen, Torsten; Flygt, Hjalmar; Lubking, Anna; Olsson-Strömberg, Ulla et al.

Ingår i Leukemia, s. 1156-1159, 2023

• DOI för The impact of Covid-19 in patients with chronic myeloid leukemia: a nationwide population-based study
• Ladda ner fulltext (pdf) av The impact of Covid-19 in patients with chronic myeloid leukemia: a nationwide population-based study

Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature

Del Giudice, Ilaria; Cappelli, Luca Vincenzo; Delgado, Julio; Niemann, Carsten Utoft et al.

Ingår i British Journal of Haematology, s. 353-356, 2023

• DOI för Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature

Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option

Dolinska, Monika; Cai, Huan; Mansson, Alma; Shen, Jingyi et al.

Ingår i Blood, s. 73-89, 2023

• DOI för Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option
• Ladda ner fulltext (pdf) av Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option

Impact of body mass index on outcome and treatment-related toxicity in young adults with acute lymphoblastic leukemia

Egnell, Christina; Hallböök, Helene; Heyman, Mats; Wartiovaara-Kautto, Ulla et al.

Ingår i Acta Oncologica, s. 1723-1731, 2023

• DOI för Impact of body mass index on outcome and treatment-related toxicity in young adults with acute lymphoblastic leukemia
• Ladda ner fulltext (pdf) av Impact of body mass index on outcome and treatment-related toxicity in young adults with acute lymphoblastic leukemia

Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia

Eriksson, Anna; Engvall, Marie; Mathot, Lucy; Österroos, Albin et al.

Ingår i Clinical Cancer Research, s. 2826-2834, 2023

• DOI för Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia

Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study

Gerbitz, Armin; Gary, Regina; Aigner, Michael; Moosmann, Andreas et al.

Ingår i Frontiers in Immunology, 2023

• DOI för Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study
• Ladda ner fulltext (pdf) av Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study

Increased plasma endostatin and GDF15 in indolent non-Hodgkin lymphoma

Hidman, Josefin; Larsson, Anders; Thulin, Måns; Karlsson, Torbjörn

Ingår i Upsala Journal of Medical Sciences, 2023

• DOI för Increased plasma endostatin and GDF15 in indolent non-Hodgkin lymphoma
• Ladda ner fulltext (pdf) av Increased plasma endostatin and GDF15 in indolent non-Hodgkin lymphoma

Feeling safe or falling through the cracks – Patients’ experiences of healthcare in cirrhosis illness: A qualitative study

Hjorth, Maria; Svanberg, Anncarin; Sjöberg, Daniel; Rorsman, Fredrik et al.

Ingår i PLOS ONE, 2023

• DOI för Feeling safe or falling through the cracks – Patients’ experiences of healthcare in cirrhosis illness: A qualitative study
• Ladda ner fulltext (pdf) av Feeling safe or falling through the cracks – Patients’ experiences of healthcare in cirrhosis illness: A qualitative study

Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry

Kennedy, Vanessa E.; Perkins, Cecelia; Reiter, Andreas; Jawhar, Mohamad et al.

Ingår i Blood Advances, s. 1713-1724, 2023

• DOI för Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry

Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient

Kinch, Amelie; Furebring, Mia; Chryssanthou, Erja; Hallböök, Helene

Ingår i Medical Mycology Case Reports, s. 26-30, 2023

• DOI för Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient
• Ladda ner fulltext (pdf) av Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient

Despite warnings, co-medication with proton pump inhibitors and dasatinib is common in chronic myeloid leukemia, but XS004, a novel oral dasatinib formulation, provides reduced pH-dependence, minimizing undesirable drug-drug interactions.

Larfors, Gunnar; Andersson, Per; Jesson, Gérald; Liljebris, Charlotta et al.

Ingår i European Journal of Haematology, 2023

• DOI för Despite warnings, co-medication with proton pump inhibitors and dasatinib is common in chronic myeloid leukemia, but XS004, a novel oral dasatinib formulation, provides reduced pH-dependence, minimizing undesirable drug-drug interactions.
• Ladda ner fulltext (pdf) av Despite warnings, co-medication with proton pump inhibitors and dasatinib is common in chronic myeloid leukemia, but XS004, a novel oral dasatinib formulation, provides reduced pH-dependence, minimizing undesirable drug-drug interactions.

MDS-Comorbidity Index using register data has prognostic impact in Swedish MDS patients

Larfors, Gunnar; Moreno Berggren, Daniel; Garelius, Hege; Nilsson, Lars et al.

Ingår i Leukemia Research, 2023

• DOI för MDS-Comorbidity Index using register data has prognostic impact in Swedish MDS patients
• Ladda ner fulltext (pdf) av MDS-Comorbidity Index using register data has prognostic impact in Swedish MDS patients

Chronic lymphocytic leukemia: Studies on cardiovascular disease, biomarkers and subclones

Larsson, Karin

2023

• Ladda ner fulltext (pdf) av Chronic lymphocytic leukemia: Studies on cardiovascular disease, biomarkers and subclones

Impact of daratumumab-based induction on stem cell collection parameters in Swedish myeloma patients

Lemonakis, Konstantinos; Tätting, Love; Lisak, Mikael; Carlson, Kristina et al.

Ingår i Haematologica, s. 610-614, 2023

• DOI för Impact of daratumumab-based induction on stem cell collection parameters in Swedish myeloma patients
• Ladda ner fulltext (pdf) av Impact of daratumumab-based induction on stem cell collection parameters in Swedish myeloma patients

Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19: An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry

Ljungman, Per; Tridello, Gloria; Pinana, Jose Luis; Ciceri, Fabio et al.

Ingår i Frontiers in Immunology, 2023

• DOI för Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19: An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry
• Ladda ner fulltext (pdf) av Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19: An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry

Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis

Lübke, Johannes; Schwaab, Juliana; Christen, Deborah; Elberink, Hanneke Oude et al.

Ingår i Journal of Allergy and Clinical Immunology, s. 581-590, 2023

• DOI för Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis

Next-generation sequencing of baseline genetic mutations and outcomes of eltrombopag and azacitidine therapy in patients with myelodysplastic syndromes and thrombocytopenia: Data from the SUPPORT clinical trial

Marques Ramos, Pedro; Choi, Jeea; Campbell, Catarina D.; Wang, Ying A. et al.

Ingår i eJHaem, s. 876-881, 2023

• DOI för Next-generation sequencing of baseline genetic mutations and outcomes of eltrombopag and azacitidine therapy in patients with myelodysplastic syndromes and thrombocytopenia: Data from the SUPPORT clinical trial
• Ladda ner fulltext (pdf) av Next-generation sequencing of baseline genetic mutations and outcomes of eltrombopag and azacitidine therapy in patients with myelodysplastic syndromes and thrombocytopenia: Data from the SUPPORT clinical trial

Population-based studies in Myelodysplastic syndromes: Prognostic scores, socioeconomic status, and therapy-related disease

Moreno Berggren, Daniel

2023

• Ladda ner fulltext (pdf) av Population-based studies in Myelodysplastic syndromes: Prognostic scores, socioeconomic status, and therapy-related disease

Therapy-related MDS dissected based on primary disease and treatment: a nationwide perspective

Moreno Berggren, Daniel; Garelius, Hege; Willner Hjelm, Petter; Nilsson, Lars et al.

Ingår i Leukemia, s. 1103-1112, 2023

• DOI för Therapy-related MDS dissected based on primary disease and treatment: a nationwide perspective
• Ladda ner fulltext (pdf) av Therapy-related MDS dissected based on primary disease and treatment: a nationwide perspective

Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications

Nilsson, Christer; Linde, Fredrika; Hulegardh, Erik; Garelius, Hege et al.

Ingår i Haematologica, s. 1015-1025, 2023

• DOI för Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications
• Ladda ner fulltext (pdf) av Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications

Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease

Novitzky-Basso, Igor; Schain, Frida; Batyrbekova, Nurgul; Webb, Thomas et al.

Ingår i PLOS ONE, 2023

• DOI för Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease
• Ladda ner fulltext (pdf) av Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease